Zwei Nobelpreisträger wollen ihre eigenen CRISPR-Patente in Europa löschen

**From the article:**

There’s a surprise twist in the battle to control genome editing.

In the decade-long fight to control CRISPR, the super-tool for modifying DNA, it’s been common for lawyers to try to overturn patents held by competitors by pointing out errors or inconsistencies.

But now, in a surprise twist, the team which earned the Nobel Prize for developing CRISPR is asking to cancel two of their own seminal patents, MIT Technology Review has learned. The decision could affect who gets to collect the lucrative licensing fees on using the technology.

­­The request to withdraw the pair of European patents, by lawyers for Nobelists Emmanuelle Charpentier and Jennifer Doudna, comes after a damaging August opinion from a European technical appeals board, which ruled the duo’s earliest patent filing didn’t explain CRISPR well enough for other scientists to use it, and doesn’t count as a proper invention.